Download presentation
Presentation is loading. Please wait.
1
OMNIBUS PROGRAM OVERVIEW
Omnibus IV Industry Day 2 – 12/7/2016 Military Medical Research Acquisition OMNIBUS PROGRAM OVERVIEW (In RFP Context) Disclaimer: This presentation is NOT intended to represent the position of the US Government (USG) Phillip Borja (Contractor) Luck Chanthabandith (Contractor)
2
Omnibus Program Overview
The following presentation is to discuss: History of Omnibus 1, 2, and 3; and Moving forward, Omnibus 4, and how it might be different from Omnibus 1, 2, and 3, in the context of the draft RFP
3
Page 11, Sec. C - Scope RFP: This comprehensive military medical requirement includes [trimetric process]: (1) research and development; (2) regulatory processes (such as clinical trials and government approvals); and (3) translational science. Translational science in this context is defined as migrating science and enhanced technology (including equipment) into the military medical treatment facilities. Opinion: Other Direct Costs (ODCs) path versus Original Equipment Manufacturer (OEM) / Value Added Reseller (VAR) paths … improving price offered to USG for technology upgrade.
4
Page 11, Sec. C – Strategic Sourcing
RFP: This is a strategic source buy as designated by the Office of the Assistant Secretary of the Army (Acquisition, Logistics & Technology). The Defense Health Agency (represented by the lead client agency Air Force Medical Service) has a broad-scope requirement for military medical research. Opinion: Growing program contract ceiling from $1B (over 3+ contracts) to (slightly less than) $1B on Omnibus 4 alone, on same scale as a GSA GWAC.
5
Page 11, Sec. C - Background (See following slides)
6
Omnibus History – Omnibus 1
Milestones 9 contracts awarded POP: Base year with 4 option periods ( ) $180M cumulative ceiling capacity ($20M/contract) – 2 contracts increased to $22M 64 Task Orders issued $84.1M ceiling awarded $58M
7
Omnibus History – Omnibus 2
Milestones 10 contracts awarded POP: Base year with 4 option periods ( ) $200M cumulative ceiling capacity ($20M/contract) 81 Task Orders issued $100M ceiling awarded $54M
8
Omnibus History – Omnibus 3
Milestones 26 contracts awarded 12 SB Lot and 14 Full and Open (LB) Lot POP: 3 year base, 2 year option period and an optional extension of 6 months ( ) $497M Ceiling $449M awarded 133 Task Orders awarded to date 1 Task Order pending award
9
Joint Program Committee (JPC) Areas
10
Capacity Performance $ Dollars
11
Page 11, Sec. C – Translational Science Objective
RFP: Objective (3) can include purchase of equipment, particularly equipment that represents an advancement in what facilities current have. Opinion: The above, coupled with OEM-rep contract holders and/or on-ramping, opens the door to cost-effective major equipment buys, allowing for the completion of the trimetric process.
12
Page 12, Sec. C – Types of Reports
RFP: Many of the reports below are intended for translational science where technology and equipment is introduced into the military treatment facilities or laboratories. Opinion: This defines the report infrastructure for introducing new technology into the military hospitals and military laboratories (such as School of Aerospace Medicine).
13
Page 15, Sec. C – Major Acquisition Deployment
RFP: Global access is defined to mean that, if applicable, the product will be distributed worldwide and will be available for worldwide public health. Opinion: Comparable to major weapon system acquisition, we could see maturation of research programs in a Joint Capabilities Integration and Development System (JCIDS) process to include Initial Capabilities, Capability Development, and Capability Production Documents (ICD, CDD, & CPD). Case in point: the TBI HBO2 Program migration from R&D to Production & Deployment into the MTFs.
14
Page 15, Sec. C – RAM RFP: This includes any reliability, availability and maintainability data. Opinion: RAM are system design attributes that have significant impacts on the sustainment or total Life Cycle Costs of a developed system transitioning from the research phase. As we migrate systems from basic research to deployed systems, RAM needs to be addressed.
15
Page 28, Sec. H – On-Ramping RFP: The objective of an on-ramp is to maintain competitive sources for Omnibus IV task orders and/or obtain access to additional capabilities. Opinion: The newest challenge is to add to the list of contract holders vendors that can provide a cost-effective offering under the translational science requirement.
16
Page 83, Sec. L – Technical Volume
RFP: The Offeror shall provide as much detail as needed to adequately illustrate the Offerors ability to perform this type of work. Opinion: The Offeror shall demonstrate the Offeror’s added value to military medical research. This may include relevance to one or more of the objectives, but not necessarily all three [trimetric process].
17
Page 84, Sec. L – Joint Ventures
RFP: If an Offeror proposes as a legal joint venture, experience examples from individual partners may be submitted; the Offeror shall note the relationship of the partner to the joint venture. Opinion: The optimum joint venture is one that is approved under the SBA 8(a) Mentor-Protégé Program where the joint venture can still qualify as a small business, regardless of the size of the participating large business mentor. Experience of large mentor can be used as joint venture’s.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.